Q4 2019 Holdings
Filed 2020-02-13 | 86 holdings | $74.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $21.3M | 251,382 | 28.6% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $15.3M | 357,000 | 20.5% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $10.3M | 73,773 | 13.8% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $8.2M | 198,781 | 11.0% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $6.2M | 1,069,089 | 8.3% |
| Burlington Stores Inc(BURL) | COM | 122017106 | $4.4M | 19,500 | 6.0% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $2.9M | 268,747 | 3.8% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $2.7M | 16,581 | 3.6% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $2.2M | 540,000 | 2.9% |
| Spdr Series Trust(XBI)Put | PUT | 78464A870 | $266.3K | 2,800,000 | 0.4% |
| Ishares TR(IBB)Put | PUT | 464287556 | $120.5K | 1,000,000 | 0.2% |
| Johnson & Johnson(JNJ) | COM | 478160104 | $64.0K | 438,653 | 0.1% |
| Bristol Myers Squibb Co(BMY) | COM | 110122108 | $58.7K | 915,000 | 0.1% |
| Sanofi(SNY) | SPONSORED ADR | 80105N105 | $57.2K | 1,140,000 | 0.1% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $50.5K | 555,000 | 0.1% |
| Novo-Nordisk A S(NVO) | ADR | 670100205 | $37.0K | 640,000 | 0.0% |
| Gilead Sciences Inc(GILD)Call | CALL | 375558103 | $32.5K | 500,000 | 0.0% |
| Seattle Genetics IncCall | CALL | 812578102 | $28.6K | 250,000 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $27.3K | 2,800,320 | 0.0% |
| Novartis A G(NVSN) | SPONSORED ADR | 66987V109 | $18.9K | 200,000 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $18.1K | 140,000 | 0.0% |
| Verint SYS Inc(VTY) | COM | 92343X100 | $16.1K | 290,699 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $12.5K | 115,713 | 0.0% |
| Teva Pharmaceutical Inds LTD(TEVA)Call | CALL | 881624209 | $12.0K | 1,220,600 | 0.0% |
| Mylan N V | SHS EURO | N59465109 | $11.3K | 560,000 | 0.0% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $10.3K | 214,736 | 0.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $10.0K | 139,514 | 0.0% |
| Microsoft Corp(MSFT) | COM | 594918104 | $9.3K | 58,741 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $8.5K | 106,000 | 0.0% |
| Exicure Inc(XCUR) | COM | 30205M101 | $8.3K | 2,888,888 | 0.0% |
| Allot LTD(ALLT) | SHS | M0854Q105 | $8.3K | 970,666 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $8.2K | 361,888 | 0.0% |
| GW Pharmaceuticals PLC | ADS | 36197T103 | $8.1K | 77,000 | 0.0% |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | $8.0K | 805,000 | 0.0% |
| Audiocodes LTD(AUDC) | ORD | M15342104 | $7.9K | 306,053 | 0.0% |
| Fiserv Inc(FISV) | COM | 337738108 | $7.8K | 67,279 | 0.0% |
| X4 Pharmaceuticals Inc(ASNSUSD) | COM | 98420X103 | $7.7K | 720,000 | 0.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $7.7K | 200,000 | 0.0% |
| Portola Pharmaceuticals Inc | COM | 737010108 | $7.6K | 317,000 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $7.4K | 868,200 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $7.3K | 256,380 | 0.0% |
| Palo Alto Networks Inc(PANW) | COM | 697435105 | $7.2K | 30,976 | 0.0% |
| Zymeworks Inc | COM | 98985W102 | $7.1K | 157,000 | 0.0% |
| Precision Biosciences Inc | COM | 74019P108 | $6.9K | 493,739 | 0.0% |
| Amazon COM Inc(AMZN) | COM | 023135106 | $6.8K | 3,700 | 0.0% |
| Y Mabs Therapeutics Inc(YMABUSD) | COM | 984241109 | $6.7K | 213,293 | 0.0% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $6.3K | 330,000 | 0.0% |
| Galera Therapeutics Inc(GRTX) | COM | 36338D108 | $6.2K | 471,439 | 0.0% |
| Minerva Neurosciences Inc(NERVGBP) | COM | 603380106 | $6.1K | 855,000 | 0.0% |
| Arqule Inc(ARQLUSD) | COM | 04269E107 | $5.9K | 297,227 | 0.0% |